BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15611085)

  • 21. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
    Qiao M; Shapiro P; Kumar R; Passaniti A
    J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RACK1 regulates integrin-mediated adhesion, protrusion, and chemotactic cell migration via its Src-binding site.
    Cox EA; Bennin D; Doan AT; O'Toole T; Huttenlocher A
    Mol Biol Cell; 2003 Feb; 14(2):658-69. PubMed ID: 12589061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit.
    Brodt P; Fallavollita L; Khatib AM; Samani AA; Zhang D
    J Biol Chem; 2001 Sep; 276(36):33608-15. PubMed ID: 11445567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.
    Pandini G; Frasca F; Mineo R; Sciacca L; Vigneri R; Belfiore A
    J Biol Chem; 2002 Oct; 277(42):39684-95. PubMed ID: 12138094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dominant negative effect of a kinase-defective insulin receptor on insulin-like growth factor-I-stimulated signaling in Rat-1 fibroblasts.
    Takata Y; Imamura T; Haruta T; Sasaoka T; Morioka H; Ishihara H; Sawa T; Usui I; Ishiki M; Kobayashi M
    Metabolism; 1996 Dec; 45(12):1474-82. PubMed ID: 8969279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RACK1 promotes neurite outgrowth by scaffolding AGAP2 to FAK.
    Dwane S; Durack E; O'Connor R; Kiely PA
    Cell Signal; 2014 Jan; 26(1):9-18. PubMed ID: 24056044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of insulin-like growth factor I (IGF-I) receptor mutants for their effects on IGF-I- and interleukin 4-mediated DNA synthesis of 32D cells.
    Yam A; Hyun T; Li W
    J Biol Chem; 2001 Jun; 276(26):24409-13. PubMed ID: 11323432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiomyocyte apoptosis triggered by RAFTK/pyk2 via Src kinase is antagonized by paxillin.
    Melendez J; Turner C; Avraham H; Steinberg SF; Schaefer E; Sussman MA
    J Biol Chem; 2004 Dec; 279(51):53516-23. PubMed ID: 15322113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein tyrosine phosphatase-alpha complexes with the IGF-I receptor and undergoes IGF-I-stimulated tyrosine phosphorylation that mediates cell migration.
    Chen SC; Khanna RS; Bessette DC; Samayawardhena LA; Pallen CJ
    Am J Physiol Cell Physiol; 2009 Jul; 297(1):C133-9. PubMed ID: 19420001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
    Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
    J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PTPmu protein-tyrosine phosphatase binds and recruits the scaffolding protein RACK1 to cell-cell contacts.
    Mourton T; Hellberg CB; Burden-Gulley SM; Hinman J; Rhee A; Brady-Kalnay SM
    J Biol Chem; 2001 May; 276(18):14896-901. PubMed ID: 11278757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.
    Maile LA; Badley-Clarke J; Clemmons DR
    Mol Biol Cell; 2003 Sep; 14(9):3519-28. PubMed ID: 12972543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor.
    Giorgetti S; Pelicci PG; Pelicci G; Van Obberghen E
    Eur J Biochem; 1994 Jul; 223(1):195-202. PubMed ID: 8033892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein tyrosine phosphorylation induced by epidermal growth factor and insulin-like growth factor-I in a rat clonal dental pulp-cell line.
    Kawase T; Orikasa M; Ogata S; Burns DM
    Arch Oral Biol; 1995 Oct; 40(10):921-9. PubMed ID: 8526802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RACK1 regulates Src activity and modulates paxillin dynamics during cell migration.
    Doan AT; Huttenlocher A
    Exp Cell Res; 2007 Jul; 313(12):2667-79. PubMed ID: 17574549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (alpha)v(beta)3 integrins and Pyk2 mediate insulin-like growth factor I activation of Src and mitogen-activated protein kinase in 3T3-L1 cells.
    Sekimoto H; Eipper-Mains J; Pond-Tor S; Boney CM
    Mol Endocrinol; 2005 Jul; 19(7):1859-67. PubMed ID: 15761030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.